1. No category

Legend
Plenary
Clinical Workshop
Other
Basic workshop
Industry Session
Poster Session
Debate
Basic and clinical workshop
Athena
Hermes
Thursday, May 14, 2015
16:30-16:45
Opening Ceremony
16:45-17:30
Keynote lecture: The J. Edmond Charlton Lecture (45
minutes)
Allan I. Basbaum, USA
Gallieni 1+2
Gallieni 5
Coffee Break
17:30-17.45
THE ENIGMA OF PAIN AND AFFECTIVE DISORDERS
COMORBIDITY IN ANIMAL MODELS AND PATIENTS
WITH NEUROPATHIC PAIN
DEBATE - NEUROPATHIC PAIN QUESTIONNAIRES ARE
SUITABLE FOR NEUROPATHIC CLASSIFICATION
17:45-19:15
19:30
Gallieni 4
Chair : A. Stubhaug
Pro: Rainer Freynhagen, Germany
Con: Per Hansson, Norway
UPDATE ON NEUROPATHIC PAIN AND INFECTIOUS
DISEASES
Chair: Aki Hietaharju, Finland
Neuropathic pain in leprosy
Andrew Rice, UK
HIV-associated sensory neuropathy
Peter Kamerman, South Africa
Postherpetic Neuralgia
Ralf Baron, Germany
POTASSIUM CHANNELS IN NEUROPATHIC PAIN:
OPTIONS FOR PHARMACORESISTANT PATIENTS WITH
Chair: Esther Berrocoso, Spain
ADVANCES, CHALLENGES AND EMERGING IDEAS
TRIGEMINAL NEURALGIA
Neuroplastic changes triggered by the comorbidity of
Chair: Alain Eschalier, France
Chair: Giorgio Cruccu, Italy
neuropathic pain and affective disorders
Emerging Kv targets for chronic pain pharmacotherapy
The problem of pharmacoresistance in trigeminal neuralgia
Esther Berrocoso, Spain
Christoforos Tsantoulas, UK
Giorgio Cruccu, Italy
The anterior cingulate cortex: a critical hub for the
M-current modulation of pain processing
Alternative options for pharmacoresistant patients
anxiodepressive consequences of neuropathic pain
Jose Lopez-Garcia, Spain
Turo Nurmikko, UK
Ipek Yalcin, France
Pathophysiology and pharmacology of potassium channels in
How to choose the type of surgical intervention
A strong association between cognitive function, anxiety and
neuropathic pain
Denis Fontaine, France
mood and the development of chronic neuropathic pain in
Jérome Busserolles, France
humans
Sophie Baudic, France
Welcome Reception
Gallieni 7
Legend
Plenary
Clinical Workshop
Other
Basic workshop
Industry Session
Poster Session
Debate
Basic and clinical workshop
Athena
Hermes
Friday, May 15, 2015
07:30-09:00
Breakfast Parallel Industry Session
Gallieni 1+2
Breakfast Parallel
Industry Session
Gallieni 5
Gallieni 4
Gallieni 7
Plenary II:
Small fiber pathology, neuropathies and pain
09:00-10:00
Diabetic neuropathies: latest developments in assessment
and therapy
Solomon Tesfaye, UK
Small fiber pathology: a culprit for many painful conditions
Nurcan Uceyler, Germany
Coffee Break, Poster Viewing, Visit Exhibition
10:00-10:30
RELEVANCE OF NEUROPHYSIOLOGIC TESTS FOR THE
STUDY OF PAINFUL NEUROPATHIES: AN UPDATE
10:30-12:00
RISK FACTORS AND PREVENTION OF POSTSURGICAL
NEUROPATHIC PAIN
PERIPHERAL SODIUM AND CALCIUM CHANNELS AS
OPPORTUNE TARGETS FOR NEUROPATHIC PAIN
TREATMENT
CHEMOTHERAPY – INDUCED PAINFUL NEUROPATHY:
LATEST PERSPECTIVES
Chair: Dib-Hajj Sulayman, USA
Chair: Rolf-Detlef Treede, Germany
Chair: Sarah Flatters, UK
Mutations in peripheral sodium channels Nav1.7, Nav1.8 and
Contact heat, cold, mechanical, electrical and chemical
Chair: Audun Stubhaug, Norway
Mitochondrial dysfunction and oxidative stress in
Nav1.9 in rare pain disorders and common peripheral
DEBATE- FIBROMYALGIA IS PRIMARILY A CENTRALIZED stimuli to elicit small fiber potentials: merits and limitations Neuropathic aspects of persistent postsurgical pain: state of
Chemotherapy-induced painful neuropathy
neuropathy
PAIN AMPLIFICATION DISORDER
for basic science & clinical use
the art
Sarah Flatters, UK
Dib-Hajj Sulayman, USA
Chair: Serge Perrot, France
Rolf-Detlef Treede, Germany
Christian Duale, France
Targeting sphingosine-1-phosphate in ChemotherapyThe contribution of specific sodium channels to pain signaling
Pro: Jules Desmeules, Switzerland
The relevance of LEPs in patients with suspected neuropathic
Psychological and somatic risk factors for neuropathic
Induced Peripheral Neuropathy
pathways
Con: Claudia Sommer, Germany
pain
postsurgical pain
Daniela Salvemini, USA
John Wood, UK
Luis Garcia-Larrea, France
Julie Bruce, UK
New psychophysical and functional findings in chemotherapyInvolvement of calcium channels in pathophysiology of
Autonomic tests for the study of painful neuropathies: where Perioperative interventions: how to individualize treatments
treated patients
neuropathic pain: electrophysiological and behavioral
do we stand ?
Audun Stubhaug, Norway
Patrick Dougherty, USA
evidences
Roy Freeman, USA
Emmanuel Bourinet, France
12:00-12:30
Break and Visit Exhibition
12:30-14:00
Poster Viewing Session 1
THE ROLE OF GLIA IN PAIN DISORDERS: FROM
RODENTS TO HUMANS
Chair: Marco Loggia, USA
Astrocyte signaling in neuropathic pain
Yong-Jing Gao, China
Microglial-neuronal signalling in the maintenance of
neuropathic pain
Marzia Malcangio, UK
Evidence of glial activation in the brain of patients with
chronic low back pain
Marco Loggia, USA
Plenary III:
From phenotyping to genotyping neuropathic pain
14:00-15:00
Reappraising NP in humans: how symptoms help disclose
mechanisms
Andrea Truini, Italy
Painful and painless channelopathies: effect of genetics
David Bennett, UK
(UN)DOUBTFUL NEP COMPONENT IN
NONNEUROPATHIC PAIN DISORDERS
Chair: Ralf Baron, Germany
15:00-16:30
Insights from questionnaires
Didier Bouhassira, France
Insights from quantitative sensory testing
Johanna Höper, Germany
Insights from brain imaging
Thomas Tölle, Germany
CENTRAL NERVOUS SYSTEM STIMULATION FOR
NEUROPATHIC PAIN: THE EVIDENCE
DEBATE - THE CULPRIT FOR CHRONIC NEUROPATHIC
PAIN IS IN THE CENTRAL NERVOUS SYSTEM
Chair: Matthias Ringkamp, USA
Pro: Anthony Dickenson, UK
Con: Jordi Serra, Spain
Coffee Break, Poster Viewing, Visit Exhibition
16:30-17:00
17:00-18:30
BRAIN IMAGING IN NEUROPATHIC PAIN: ROLE IN
Parallel Industry Session
EXPERIMENTAL DESIGN, CONDUCT AND REPORTING
OF IN VIVO NEUROPATHIC PAIN MODELLING:
DEVELOPING CLINICALLY USEFUL CANNABINOID
Chair: Luis Garcia-Larrea, France
ASSESSING MECHANISMS AND TREATMENT EFFECTS
RELATED ANALGESICS FOR NEUROPATHIC PAIN
WORKING TOWARDS SUCCESFUL TRANSLATION
Evidence-based studies in neurostimulation: a difficult task
Chair: Karen Davis, Canada
Chair: Rafael, Maldonado, Spain
Chair: Andrew Rice, UK
but we are moving forward
Brain imaging of treatment effects in chronic pain conditions
Clinical limitations of conventional CB1 agonists
Multi-centre animal studies- the way forward for
Giorgio Cruccu, Italy
Karen Davis, Canada
Turo Nurmikko, UK
translational research?
Evidence-based efficacy of spinal cord stimulation in
Brain network properties predict individual variability in
FAAH inhibition: a new therapeutic target for neuropathic
Andrew Rice, UK
neuropatic pain
analgesia related to psychological aspects of treatment in Back to basics- the importance of pharmacology in the design
pain
Rod Taylor, UK
chronic pain patients
Daniele Piomelli, Italy
and conduct of experiments
Motor cortex stimulation in neuropathic pain: from anecdote
Javeria Hashmi, USA
CB2 receptor agonists for the prevention of neuropathic pain
Jeffrey Kennedy, USA
to evidence
The maladaptive neuroplasticity theory - 20 years on Martin
development
Experimental design, conduct and reporting in studies of
Luis Garcia-Larrea, France
Diers, Germany
Rafael Maldonado, Spain
animal models of neuropathic pain
Gilllian Currie, UK
Parallel Industry Session
Legend
Plenary
Clinical Workshop
Other
Basic workshop
Industry Session
Poster Session
Debate
Basic and clinical workshop
Athena
Hermes
Gallieni 1+2
Breakfast Parallel Industry Session
Breakfast Parallel
Industry Session
Saturday, May 16, 2015
07:30-09:00
Gallieni 5
Gallieni 4
Gallieni 7
AUTO-IMMUNE PAIN-AN EMERGING CONCEPT
SELECTIVE SMALL MOLECULE ANGIOTENSIN II TYPE 2
RECEPTOR (AT2R) ANTAGONIST AS POTENTIAL NOVEL
ANALGESICS FOR RELIEF OF NEUROPATHIC AND
INFLAMMATORY PAIN
Plenary IV:
Neuropathic pain and the brain
09:00-10:00
Functional brain imaging: what has it brought to our
understanding of neuropathic pain?
Roland Peyron, France
Cortical neurostimulation for NP: state of the art and
perspectives
Jean-Pascal Lefaucheur, France
Coffee Break, Poster Viewing, Visit Exhibition
10:00-10:30
DEBATE
OPIOIDS HAVE NO PLACE IN THE MANAGEMENT OF
NEUROPATHIC PAIN
10:30-12:00
Chair: Andrew Moore, UK
Pro: Cathy Stannard, UK
Con: Elon Eisenberg, Israel
DO THE EYES HAVE IT? SPATIAL REPRESENTATIONS,
CLINICAL ASSESSMENT OF NEUROPATHIC PAIN:
PAIN IN CNS DISORDERS-ARE WE MOVING FORWARD MULTI SENSORY INTERACTION AND VISUAL ILLUSIONS
FROM QUESTIONNAIRES TO QUANTITATIVE SENSORY
?
IN NEUROPATHIC PAIN
TESTING - practical
Chair: Troels J. Jensen, Denmark
Pain in Parkinson’s Disease: time to move forward
Daniel Ciampi de Andrade, Brazil
Post-Stroke Pain
Luis Garcia-Larrea, France
Pain in multiple sclerosis and other inflammatory
demyelinating diseases
Andrea Truini, Italy
Chair: Tasha Stanton, Australia
Targeting perceptual dysfunction in people with pain
Tasha Stanton, Australia
Can seeing your body help? The role of visual feedback in
musculoskeletal and neuropathic pain
Martin Diers, Germany
The influence of visuo-spatial processing on pain
Diana Torta, Belgium
Chair: Per Hansson, Norway
Detection of neuropathic pain: how to use the screening
tools ?
Michel Lanteri-Minet, France
Clinical sensory examination
Per Hansson, Norway
QST: general principles and practical applications
Helena Krumova, Germany
12:00-12:30
Break & Visit Exhibition
12:30-14:00
Poster Viewing Session 2
Chair: Steven McMahon, UK
Chair: Maree Smith, Australia
The role of immune system in the generation of neuropathic
Analgesic Efficacy and Mode of Action of Small Molecule
pain
AT2R Antagonists in Rodent Models of Neuropathic and
Steven McMahon, UK
Inflammatory Pain
Pain associated with autoantibodies
Maree Smith, Australia
Angela Vincent, UK
Clinical Mechanism of Action of AT2R Antagonists in Chronic
Immunoglobulin for the treatment of peripheral neuropathy
Neuropathic Pain
and CRPS
Praveen Anand, UK
Stefano Tamburin, Italy
Clinical Evaluation of AT2R Antagonists for Neuropathic Pain
Andrew Rice, UK
Plenary V:
Psychological and emotional aspects of neuropathic
pain
14:00-15:00
Placebo, nocebo and neuropathic pain
Lene Vase, Denmark
Fear of pain in children and adolescents with neuropathic
pain and CRPS
Laura Simons, USA
THERAPEUTIC MANAGEMENT OF NEUROPATHIC PAIN:
NEWER NEUPSIG RECOMMENDATIONS
15:00-16:30
Chair: Nanna Finnerup, Denmark
Presentation of the NEUPSIG methodology
Nadine Attal , France
NEUPSIG recommendations on drug treatment of
neuropathic pain
Nanna Finnerup, Denmark
NEUPSIG recommandations on interventional therapy for
neuropathic pain
Srinivasa Raja, USA
PHENOTYPING NEUROPATHIC PAIN FOR GENETIC AND
CLINICAL STUDIES : FROM MICE TO MEN
IS CRPS A NEGLECT-LIKE DISORDER?
Chair: Lorimer Moseley, Australia
Spatially-defined deficits in CRPS
Lorimer Moseley, Australia
Attending to and representing the body and the space
around it
Alberto Gallace, Italy
Disrupted body representation phenomena in CRPS
Annika Reinersmann, Germany
Chair: Peter Kamerman, South Africa
Phenotyping for genetic studies in animal models of
neuropathic pain
Ze'ev Seltzer, Canada
NeuroPPIC: Neuropathic pain phenotyping by international
consensus?
Peter Kamerman, South Africa
Phenotyping in clinical trials of neuropathic pain
Didier Bouhassira, France
Coffee Break & Visit Exhibition
16:30-17:00
17:00-18:30
NEUROPATHIC ITCH
Chair: Allan Basbaum, USA
Neuropathic itch: an overview
Earl Carstens, USA
Presentation title TBA
Matthias Ringkamp, USA
Presentation title TBA
Rolf-Detlef Treede, Germany
Parallel Industry Session
Parallel Industry Session
SYSTEM BIOLOGY IN NEUROPATHIC PAIN – NEW
APPROACH, NEW MECHANISTIC INSIGHT
LESSONS TO BE LEARNED FROM CLINICAL AND
PRECLINICAL META ANALYSES
Chair: Tim Hucho, Germany
Analysis of intracellular signaling networks indicates novel
therapeutic strategies
Tim Hucho, Germany
Insights into neuropathic pain provided by transcriptome
analysis
David Bennett, UK
Evolutionary genome analysis reveals novel pain genes and
therapeutic targets
Greg Neely, Australia
Chair: Gilllian Currie, UK
Challenges in pre-clinical meta-analyses of neuropathic pain,
focus on animal models
Gilllian Currie, UK
Detecting publication bias and the impact on both preclinical
and clinical research
Emily Sena, UK
Challenges in clinical meta-analyses in neuropathic pain
Haroutounian Simon, USA
Legend
Plenary
Clinical Workshop
Other
Basic workshop
Industry Session
Poster Session
Debate
Basic and clinical workshop
Athena
Hermes
Gallieni 1+2
Breakfast Parallel Industry Session
Breakfast Parallel Industry Session
Sunday, May 17, 2015
07:30-09:00
Gallieni 5
Plenary VI:
Molecular mechanisms, translational approach of
neuropathic pain
09:00-10:00
Experimental models of neuropathic pain: validity and
limitations
Andreas Binder, Germany
Understanding the neural substrates of chronic neuropathic
pain: role of microglia
Michael Salter, Canada
Coffee Break
10.00-10.30
SMALL FIBERS, LARGE EFFECTS – A NEW ROLE IN
FIBROMYALGIA SYNDROME ?
10.30-12.00
12:00-13:00
Chair: Nurcan Üçeyler, Germany
Fibromyalgia: to be or not to be... neuropathic ?
Serge Perrot, France
Small fiber pathology in patients with fibromyalgia syndrome
Anne Louise Oaklander, USA
Abnormalities in peripheral C-nociceptors of patients with
fibromyalgia syndrome
Jordi Serra, Spain
AFFECTIVE AND COGNITIVE PAIN MODULATION IN
NEUROPATHIC PAIN Chair: Mark Jensen, USA
Thalamic dysregulation and neuropathic pain
Sylvia Gustin, Australia
Expectation and pain relief: impact on brain activity
Christian Büchel, Germany
Modulation therapy of neuropathic pain (hypnosis,
meditation, mindfulness, ): state of the art
Mark Jensen, USA
CONFOCAL CORNEAL MICROSCOPY (CCM) – A NEW
DIAGNOSTIC TOOL FOR NEUROPATHY OR THE NEXT
HYPE?
Chair: Christoph Maier, Germany
An overview of CCM methodology
Rayaz Malik, UK
Reliability and diagnostic pitfalls of CCM
Tunde Peto, UK
CCM, skin punch biopsy and QST- comparison of the
diagnostic validity in neuropathic pain
Maier Christoph, German
PERSISTENT IDIOPATHIC FACIAL PAIN: MECHANISMS
AND MANAGEMENT
Chair: Barry Sessle,
Canada
Extraterritorial behavioral hypersensitivity and dorsal horn
central sensitization in trigeminal neuropathic pain models:
role of glial and genetic factors
Barry Sessle, Canada
Neuron-glial interactions contribute to extraterritorial spread
in trigeminal neuropathic pain
Koichi Iwata, Japan
Assessment and management of orofacial neuropathic and
idiopathic facial pain in humans
TBA
Closing Ceremony and Prize Presentations
Gallieni 4
Gallieni 7